Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Teneligliptin

Generic Name: Teneligliptin

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₀N_₆OS

CAS Number: 760937-92-6

Unique Ingredient Identifier: 28ZHI4CF9C

Overview

Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.

Background

Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.

Indication

用于2型糖尿病患者。

Associated Conditions

Type 2 Diabetes Mellitus

Clinical Trials

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Phase 1

Recruiting

Posted: 2025/03/21

Sponsor:Handok Inc.

ID:NCT06889350

Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Phase 1

Completed

Posted: 2024/04/01

Sponsor:Handok Inc.

ID:NCT06339788

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin

Phase 3

Completed

Posted: 2022/08/17

Sponsor:Handok Inc.

ID:NCT05504239

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

Phase 3

Completed

Posted: 2022/08/17

Sponsor:Handok Inc.

ID:NCT05504226

A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen

Phase 4

Completed

Posted: 2020/06/24

Sponsor:Yonsei University

ID:NCT04446026

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy